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ABSTRACT
Safe and wholesome food is essential for good health.  Therefore, when one considers health issues
related to unsafe foods, recorded morbidity and mortality as well as economic losses in a population
must be included.  Due to their presence in unsafe food, micro-organisms are generally considered
to pose a major risk to human health.  In aquaculture, chemicals are used mainly in the treatment
and prophylaxis of disease problems, which constitute the largest single cause of economic losses.
However, the increasing use of chemicals in aquaculture has led to wide-spread public concern.
The concerns related to human health due to chemical use in aquaculture are repeatedly found in
the published literature.  They include allergic reactions in previously sensitized persons triggered
by chemical residues, and the potential impacts on human health resulting from the emergence of
drug-resistant bacteria caused by the use of sub-therapeutic levels of antibiotics and by antibiotic
residues persisting in the sediments of aquaculture environments.  This paper discusses the risk
evaluation principles, data requirements and the concept of maximum residue limit.  The
uncertainties inherent in the process include, but are not limited to, the state-of-the-art of
toxicological evaluation, the level of understanding of the environmental transport process of
chemicals, the exposure data available, and any assumptions and extrapolations.
_______________
1 This paper expresses the views of the authors and does not represent those of any organization men-
tioned in the text.
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INTRODUCTION
A major objective of risk evaluation/assessment of chemicals is to provide a reliable basis for sound
management of toxic chemicals.  The Joint FAO/WHO Expert Consultation on Application of
Risk Analysis to Food Standards Issues which was held in Geneva, Switzerland from 13-17 March,
1995 supports the use of a science-based risk assessment process (FAO/WHO 1995).  The concept
of maximum residue limits of veterinary drugs adopted in 1989 by the Commission of the Codex
Alimentarius was discussed as an approach aimed at guaranteeing the absence of chemical residues
that might present a risk to consumer health (Boisseau 1993).
DECISION PROCESS FOR ESTABLISHING RECOMMENDED
MAXIMUM RESIDUE LIMITS
In recommending a Maximum Residue Limit (MRL) for a specific compound, several factors are
taken into account by the Committee.  Among these are the results of toxicological and radio-
labelling residue studies, the bioavailability of bound residues, the identification of target tissue(s),
the existence of a residue marker for determining compliance with safe residue limits, residue data
from use of the veterinary drug according to good practice in the use of veterinary drugs, withdrawal
periods for adequate residue depletion, and practical analytical methods for residue analysis.
The first step in establishing a recommended MRL is the determination of an Acceptable Daily
Intake (ADI) based on the available toxicological data.  If the use of a veterinary drug according to
good practice in the use of veterinary drugs yields concentrations of residues lower than those
corresponding to the ADI, the MRL will be reduced accordingly.  However, if the residues cannot
be measured using a practical analytical method under these conditions of use, the MRL will be
raised so that compliance with the MRL may be checked analytically.  In no instance, however, will
an MRL be recommended at concentrations that significantly exceed the MRL based on toxicological
considerations.
An important factor to be considered in the establishment of MRLs in various edible tissues and
other products of animal origin is the amount of the food item consumed.  In order to protect all
segments of the population, it is reasonable to use intake data at the upper limit of the range for
individual edible tissues and animal products.  The Committee based its recommendations on the
following daily intake values: 300 gm of meat (as muscle tissue), 100 gm of liver, 50 gm of kidney,
50 gm of tissue fat, 100 gm of egg and 1.5 L of milk (WHO 1990), figures that are believed to
protect the vast majority of the population of the world (WHO 1989).  “The human consumption
of farmed fish and prawns, for example, seems to vary considerably, and accurate food intake data
are difficult to obtain at the international level.  In order to protect all segments of the population,
MRLs for these food commodities should be based on the food intake values noted in the 34th
report of the committee” (WHO 1995b).  It is recommended that governments consider whether
local diets may result in intakes that exceed the ADI (WHO 1995a).
RELEVANT DATA FOR ASSESSING THE HUMAN FOOD SAFETY
OF RESIDUES OF VETERINARY DRUGS
When investigating the safety of the consumption of residues of veterinary drugs in food, the
Committee requires detailed reports (including individual animal data) of the following types of
studies relevant to the toxicological evaluation:
● Pharmacokinetic, metabolic and pharmacodynamic studies in experimental and food-
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producing animals, and in humans, when available.
● Short-term and long-term carcinogenicity, reproduction and developmental studies in
experimental animals, and genotoxicity studies.
● Special studies designed to investigate specific effects, such as those on mechanisms of toxicity,
non-hormonal-effect levels, immune responses and macro-molecular binding.
● For compounds with antimicrobial activity, studies by the manufacturer designed to evaluate
the possibility that the compound might have an adverse effect on the microbial ecology of
the human intestinal tract.
● Studies providing relevant data on the use of, and exposure to, the drug in humans, including
studies of effects observed after occupational exposure and epidemiological data following
clinical use in humans.
Detailed reports of studies relevant to the evaluation of drug residues in food-producing animals
that are required for evaluation include information on the chemical identity and properties of the
drug, its use and dose range.
As for the toxicological evaluation, pharmacokinetic and metabolic studies in experimental animals,
target animals and humans, are needed.  These include:
● Residue-depletion studies with radio-labelled drug in target animals from zero withdrawal
time to periods extending beyond the recommended withdrawal time.  These studies should
provide information on total residues, including free and bound residues, and major residue
components to permit selection of a marker residue and target tissue.
● Residue-depletion studies with unlabelled drug for the analysis of marker residue in target
animals and in eggs, milk and honey.   These should include studies with appropriate
formulations, routes of application, and species, at doses up to the maximum recommended.
Also required are:
● A review of routine analytical methods that may be used by regulatory authorities for the
detection of residues in target tissue.
● A description of the analytical procedures used by the sponsor for the detection and
determination of parent drug residues.  The sponsor is also required to describe a method
that may be used by regulatory authorities for the specific determination of the marker residue
with a sensitivity equal to or less than the MRL (WHO 1995a).
SOME ISSUES OF PUBLIC CONCERN AND THE SAFETY EVALUATION
PROCESS
Issue of Risk Due to Allergic Reactions Due to Chemical Residues in Foods
Although allergic reactions caused by antibiotic residues in food are of great public concern, it is
found that, in general, the incidence of allergic reaction following ingestion of antibiotic residues
in food animals is very low (Adkinson 1980, Black 1984).  Many drugs, such as penicillins,
tetracyclines, sulfonamides and some aminoglycosides, are considered to have a high potential for
sensitizing susceptible individuals.  Penicillins have the greatest potential and cause allergic response
characterized by dermatitis in most reports.  It is implied that the amount of penicillin required to
induce the primary sensitization may be greater than the quantities eliciting an allergic response
(about 1-10 units or less) (Adkinson 1980), and that dairy products that test negative by
microbiological assay may contain sufficient penicillin or its metabolites to maintain urticaria (Boonk
and Van Ketel 1982).  According to these studies, it is indicated that very minute levels of penicillin
in food can cause allergic reactions.
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WHO (1990) stated that “Although there is no evidence from which threshold doses for such
effects can be determined, the Committee concluded that hypersensitivity reactions due to the
ingestion of food of animal origin containing allergic drug residues were unlikely to be of major
health significance.  This view was supported by the small numbers of reports in the published
literature.  Nevertheless, the Committee recognized that reactions could occur in highly sensitized
individuals and therefore recommended that residues of drugs with known or suspected allergenic
properties be kept as low as practicable, particularly penicillin and other β-lactam antibiotics such
as the cephalosporins.”
Difficulty still exists concerning the strategy and approach to be used for evaluating this risk,
especially when a chemical residue may trigger an allergic reaction in a previously sensitized person
or may undermine the immune system.
Issue of Microbial Resistance Due to the Use of Sub-therapeutic Levels of Antibiotic
The predominant public concerns on microbial resistance due to the use of sub-therapeutic levels
of antibiotics are the possible impacts on human health resulting from the emergence of drug-
resistant bacteria in animals caused by the prolonged use of low-level antibiotics in animal feed
(Gersema and Helling 1986, Sorum et al. 1992), and that antibiotic residues (i.e., residues of
oxytetracycline and oxolinic acid) may persist in sediment for a long time (Pedersen et al. 1995).
These situations actually bring humans to new medical dilemma.
Recently published studies have implied that the transmission of antibiotic-resistant pathogenic
bacteria of animal origin to man may be possible, and is apparently related to the sub-therapeutic
use of these drugs in animal production.  Furthermore, the resistant strains in the environment
may also transfer R plasmid to human intestinal flora (Levy et al. 1976a, b;  Holmberg et al.
1984a, b).  Therefore, such antibiotic-resistant bacteria may be direct or indirect causes of human
illness, and the induction a significant loss of antibiotic efficacy in bacterial infection treatments,
as, for example, in the case of the Salmonella outbreak in the United States in1971-1983 (Cohen
and Tauxe 1986).  Nevertheless, this topic is still controversial, and there is no direct evidence by
reason of the difficulties in tracing the resistant strains from animal to man and the complexity of
antibiotic use in humans (Black 1984).
In assessing the microbiological risk due to residues of antimicrobial drugs in food, WHO (1990)
stated that “In evaluating the safety of residues of antimicrobial drugs, the specific risks associated
with their antimicrobial activity should be considered in addition to their pharmacological properties.
The anti-microbial activity could become the determining factor of this safety evaluation if the
toxicity of the substance to be considered is such that higher levels of residues could be tolerated in
food on a toxicological basis.”
In this respect, the Codex Committee on Residues of Veterinary Drugs in Foods has adopted a
definition of Maximum Residue Limit for Veterinary Drugs taking into account “other relevant
public health risks (that may refer to allergic and microbiological risks) as well as food technological
aspects.”
In assessing the microbiological risk, two biological systems need to be considered, the intestinal
flora of the consumer, and the bacteria used in the food processing industry.  The risk being
considered by the Committee does not include potential health effects associated with ingesting
food of animal origin that contains resistant bacteria selected under the pressure of antimicrobial
therapy, because the Committee’s terms of reference include only the safety assessment of drug
residues (WHO 1990).
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INHERENT UNCERTAINTIES IN THE SAFETY EVALUATION PROCESS
The uncertainties inherent in the risk assessment process include, but are not limited to, the state-
of-the-art of toxicological evaluation, the level of understanding of the environmental transport
process of chemicals, the exposure data available, and any assumptions and extrapolations.
Pharmacokinetic studies also become more complicated when there is the possibility of repeated
exposure due to environmental transport processes in the aquatic environment.  This limited
understanding of the environmental fate of chemicals will contribute to uncertainty in risk evaluation.
CONCLUSIONS
Adherence to scientific principles is the most important factor in maintaining consistency in
assessments of health risk, although there are differing pharmacological and toxicological properties
of chemicals used in aquaculture and widely varying amounts of information available on them.
An approach, aimed at guaranteeing the absence of chemical residues that might present a risk to
consumer health, is the concept of maximum residue limits of veterinary drugs in foods, used by
the Commission of the Codex Alimentarius  (Boisseau 1993).
The risk evaluation/assessment process is generally accepted to provide a reliable basis for identifying
and managing health risks.  However, in some areas of public concern, such as the triggering of
allergic reactions in previously sensitized persons by chemical residues and the issue of microbial
resistance due to the use of sub-therapeutic levels of antibiotics, difficulties exist concerning the
strategy and approach for risk evaluation (Black 1984).
Uncertainties exist due to a lack of knowledge of the impacts of chemical use on multiple species
and the multiple routes of exposure in an ecosystem.  They are also due to limited knowledge of
the environmental transport of chemicals, which affects exposure of aquatic organisms to chemicals.
This, in turn, affects the pharmacokinetics and metabolism of such chemicals, resulting in changing
of the chemical residue profile within the organism.
The complexity of these issues, and often the lack of data as well as the lack of monitoring and
surveillance systems, are the factors limiting the risk analysis process.  This insufficiency of data is
more pronounced in developing countries, where resources are more limited or less available.
Therefore, only the policy of safe and effective use of chemicals must be developed.  Appropriate
strategies must be chosen, according to individual country’s and region’s needs.  Strengthening
research efforts and programs for human training and development, as well as enhancing mechanisms
for information exchange, may be encouraged through international collaboration.
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